{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:39:17Z","timestamp":1789886357882,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Hacettepe University Scientific Research Projects Coordination Unit"}],"content-domain":{"domain":["ajconline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.amjcard.2014.12.021","type":"journal-article","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T23:39:36Z","timestamp":1419032376000},"page":"647-651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Effects of Persistent Atrial Fibrillation on Serum Galectin-3 Levels"],"prefix":"10.1016","volume":"115","author":[{"given":"Kadri Murat","family":"Gurses","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed Ulvi","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duygu","family":"Kocyigit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hande","family":"Canpinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu","family":"Evranos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikmet","family":"Yorgun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Levent","family":"Sahiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ergun Baris","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Necla","family":"Ozer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lale","family":"Tokgozoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Ali","family":"Oto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dicle","family":"Guc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kudret","family":"Aytemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2014.12.021_bib1","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","article-title":"Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction","volume":"110","author":"Sharma","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2014.12.021_bib2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.cca.2009.09.001","article-title":"The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients","volume":"409","author":"Lin","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.amjcard.2014.12.021_bib3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3909\/ricm0624","article-title":"Galectin-3: a novel blood test for the evaluation and management of patients with heart failure","volume":"12","author":"McCullough","year":"2011","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.amjcard.2014.12.021_bib4","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2012.04.053","article-title":"Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community","volume":"60","author":"Ho","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2014.12.021_bib5","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/ejhf.21","article-title":"Plasma galectin 3 and heart failure risk in the Physicians' Health Study","volume":"16","author":"Djousse","year":"2014","journal-title":"Eur Heart Fail"},{"key":"10.1016\/j.amjcard.2014.12.021_bib6","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.cardfail.2014.07.018","article-title":"Plasma galectin-3 and heart failure outcomes in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial\u2013Cardiac Resynchronization Therapy)","volume":"20","author":"Stolen","year":"2014","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.amjcard.2014.12.021_bib7","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ahj.2014.02.011","article-title":"Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: a pooled analysis of 3 clinical trials","volume":"167","author":"Meijers","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2014.12.021_bib8","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1161\/01.CIR.96.4.1180","article-title":"Histological substrate of atrial biopsies in patients with lone atrial fibrillation","volume":"96","author":"Frustaci","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2014.12.021_bib9","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/hrt.2003.015347","article-title":"Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease","volume":"90","author":"Boldt","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2014.12.021_bib10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.0000109495.02213.52","article-title":"Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation","volume":"109","author":"Xu","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2014.12.021_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5543\/tkda.2014.20726","article-title":"The degree of left atrial structural remodeling impacts left ventricular ejection fraction in patients with atrial fibrillation","volume":"42","author":"Akkaya","year":"2014","journal-title":"Turk Kardiyol Dern Arsivi"},{"key":"10.1016\/j.amjcard.2014.12.021_bib12","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ahj.2014.02.009","article-title":"Galectin 3 and incident atrial fibrillation in the community","volume":"167","author":"Ho","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2014.12.021_bib13","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/europace\/eus305","article-title":"2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation\u2013developed with the special contribution of the European Heart Rhythm Association","volume":"14","author":"Camm","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.amjcard.2014.12.021_bib14","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/europace\/euq350","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"12","author":"Camm","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.amjcard.2014.12.021_bib15","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1161\/01.CIR.92.7.1954","article-title":"Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats","volume":"92","author":"Wijffels","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2014.12.021_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/01.CIR.100.1.87","article-title":"Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort","volume":"100","author":"Li","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2014.12.021_bib17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0008-6363(02)00258-4","article-title":"Electrical, contractile and structural remodeling during atrial fibrillation","volume":"54","author":"Allessie","year":"2002","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.amjcard.2014.12.021_bib18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1161\/CIRCIMAGING.109.865683","article-title":"Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation: relationship to left atrial structural remodeling detected by delayed-enhancement MRI","volume":"3","author":"Kuppahally","year":"2010","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.amjcard.2014.12.021_bib19","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/S0735-1097(00)00611-2","article-title":"Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation","volume":"35","author":"Goette","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2014.12.021_bib20","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1161\/01.RES.0000129579.59664.9d","article-title":"Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1","volume":"94","author":"Verheule","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.amjcard.2014.12.021_bib21","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1161\/01.RES.0000046452.67724.B8","article-title":"Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy","volume":"91","author":"Manabe","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.amjcard.2014.12.021_bib22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1253\/circj.CJ-10-0758","article-title":"High plasma concentrations of transforming growth factor-beta and tissue inhibitor of metalloproteinase-1: potential non-invasive predictors for electroanatomical remodeling of atrium in patients with non-valvular atrial fibrillation","volume":"75","author":"Kim","year":"2011","journal-title":"Circ J"},{"key":"10.1016\/j.amjcard.2014.12.021_bib23","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/europace\/eum072","article-title":"Circulating levels of collagen type I degradation marker depend on the type of atrial fibrillation","volume":"9","author":"Tziakas","year":"2007","journal-title":"Europace"},{"key":"10.1016\/j.amjcard.2014.12.021_bib24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jacc.2008.03.045","article-title":"Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type-I turnover","volume":"52","author":"Kallergis","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2014.12.021_bib25","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.jacc.2012.06.048","article-title":"Elevated pre-operative serum peptides for collagen I and III synthesis result in post-surgical atrial fibrillation","volume":"60","author":"Swartz","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2014.12.021_bib26","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1540-8167.2011.02059.x","article-title":"Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence","volume":"22","author":"Okumura","year":"2011","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.amjcard.2014.12.021_bib27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.hrthm.2011.11.013","article-title":"Long-term effects of catheter ablation for lone atrial fibrillation: progressive atrial electroanatomic substrate remodeling despite successful ablation","volume":"9","author":"Teh","year":"2012","journal-title":"Heart Rhythm"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291491402284X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291491402284X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T17:52:35Z","timestamp":1650822755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000291491402284X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S000291491402284X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2014.12.021","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Persistent Atrial Fibrillation on Serum Galectin-3 Levels","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2014.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}